ESC 365 - The cardiac myosin inhibitor mavacamten reduces even extreme left ventricular outflow gradient in obstructive hypertrophic cardiomyopathy already after one week of treatment

Delegates Premium Access

The cardiac myosin inhibitor mavacamten reduces even extreme left ventricular outflow gradient in obstructive hypertrophic cardiomyopathy already after one week of treatment

Session: Imaging of the hypertrophied left ventricle

Topic: Myocardial Disease

Speaker: Doctor V. Nagy (Szeged, HU)

Event: EuroEcho-Imaging 2024

Congress Presentation

Add to my library

About the speaker

Doctor Viktoria Nagy

University of Szeged, Szeged (Hungary)

0 follower

4 more presentations in this session

Right atrial strain in Anderson-Fabry disease

Speaker: Doctor R. Lillo (Rome, IT)

Abnormal right ventricular strain predicts poor prognosis in transthyretin amyloidosis

Speaker: Doctor S. Istratoaie (Cluj Napoca, RO)

Differential diagnosis of hypertrophic cardiomyopathy, fabry cardiomyopathy and transthyretin cardiac amyloidosis: insights from right ventricular strain imaging echocardiography

Speaker: Doctor E. Mata (Creixomil, PT)

Mavacamten reduces left ventricular mechanical dispersion in hypertrophic obstructive cardiomyopathy

Speaker: Doctor B. Ozbay (Pittsburgh, US)

Access the full session

Imaging of the hypertrophied left ventricle

Speakers: Doctor V. Nagy, Doctor R. Lillo, Doctor S. Istratoaie, Doctor E. Mata, Doctor B. Ozbay

About the event

EuroEcho-Imaging 2024

11 December - 13 December 2024

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources